Barcelona is calling! As the medical writing landscape shifts toward an AI-integrated future, Geninvo is proud to be at the forefront as a sponsor and exhibitor at the European Medical Writers Association (EMWA) 61st Spring Conference.
From May 5–8, 2026, the global medical writing community will gather in beautiful Barcelona to discuss the future of the industry. Whether you are navigating the complexities of the new AI Masterclasses or looking for ways to streamline your QC process, the Geninvo team is ready to help you bridge the gap between technology and science.
Visit us at Booth #10
Stop by our booth to chat with our experts, see live demos, and discover how our “Innovation First” mindset can solve your most pressing documentation challenges.
- 📅 Dates: May 5 – 8, 2026
- 📍 Location: Barceló Sants, Barcelona, Spain
- 🆔 Booth: #10
Why Connect with GENINVO in EMWA 2026 Barcelona?
GENINVO: Transforming Regulatory Writing Workflows
GENINVO is the go-to partner for life science organizations, providing intelligent document management solutions purpose-built for pharmaceutical and biotech companies. Our innovative suite of tools addresses the critical challenges medical writers face in creating compliant, accurate, and secure regulatory and scientific documentation.
DocWrightAI™ revolutionizes document creation by automating the generation of clinical study reports, investigator brochures, regulatory submissions, and other technical documents. It integrates with multiple data sources and features AI-powered validation and verification to ensure all generated documents meet internal and regulatory standards and guidelines.
DocQC™ automates quality control checks that historically required multiple time-consuming manual review cycles. Using adaptive AI and ML algorithms, it validates citations, abbreviations, in-text data against source tables, and compares Clinical Study Reports with Protocols and Statistical Analysis Plans enabling medical writers to focus on science.
Shadow™ is a sophisticated data anonymization and de-identification tool compliant with EMA Policy 0070, Health Canada, and other data transparency requirements. It performs rigorous quantitative and qualitative risk assessments, maintains data utility while executing precise redaction/anonymization activities, and supports secure data sharing.
CIS (Confidential Information Scanner)™ is an AI-powered solution that automatically detects and protects commercially confidential information across 50+ specific categories.
Expert Insight: The EMWA 2026 theme highlights “Moving from Content Creator to Process Owner.” At Booth #10, we’ll show you exactly how our tools empower you to make that transition seamlessly.
Schedule a Private Demo
Will you be in Barcelona? Don’t leave your technology strategy to chance. We invite you to schedule a one-on-one session with our leadership team during the conference to discuss your specific organizational needs.
